financetom
Business
financetom
/
Business
/
Canadian oil producers forecast higher production in 2025
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canadian oil producers forecast higher production in 2025
Dec 12, 2024 10:43 AM

By Sourasis Bose

Dec 12 (Reuters) - Three of Canada's biggest oil

producers, Suncor Energy ( SU ), Cenovus Energy ( CVE ) and

Imperial Oil ( IMO ), on Thursday projected higher production

in 2025, betting on resilient demand for Canadian crude to U.S.

and international markets.

Fuel demand in the United States, the biggest destination

for Canadian crude, is expected to rise next year as U.S.

industrial activity is likely to get a boost from a cut in

borrowing rates, according to the U.S. Energy Information

Administration.

Calgary, Alberta-based Suncor forecast 2025 production to be

between 810,000 and 840,000 barrels per day (bpd) next year, a

4.4% rise at midpoint compared to projected output for 2024.

Cenovus forecast a 4.4% increase in 2025 crude output,

targeting 805,000 to 845,000 barrels of oil equivalent per day,

primarily driven by the Narrows Lake oil sands asset startup.

Imperial Oil ( IMO ) expects a 3.1% production increase.

The Trans Mountain pipeline expansion which has nearly

tripled oil flow to Canada's Pacific Coast from landlocked

Alberta, is also encouraging producers to increase output in

hopes of shipping more crude to Asian refineries and the U.S.

West Coast.

Suncor also forecast a slight rise in refinery throughput

volumes to between 435,000 and 450,000 bpd in 2025. It expects

refining utilization to be between 93% and 97%.

While Cenovus and Imperial raised 2025 capital spending

expectations marginally, Suncor slightly lowered expected

capital expenditure for 2025 to the range of C$6.1 billion

($4.31 billion) and C$6.3 billion.

Thursday's forecast by the Canadian oil firms follows an

announcement by Exxon Mobil ( XOM ), the majority owner of

Imperial, saying it aims to increase its output by 18% by the

end of the decade.

The Canadian firms also said they planned to boost

production at current sites while simultaneously pursuing new

projects.

($1 = 1.4159 Canadian dollars)

(Reporting by Sourasis Bose, Arunima Kumar, Vallari Srivastava,

Tanay Dhumal and Seher Dareen in Bengaluru; Editing by Tasim

Zahid, Shounak Dasgupta and Sriraj Kalluvila)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alpine Banks' Q3 profit rises on higher interest income
Alpine Banks' Q3 profit rises on higher interest income
Oct 30, 2025
Overview * Alpine Banks Q3 net income rises to $18.5 mln, reflecting strong financial performance * Company's net interest margin improves to 3.54% from 3.50% in prior qtr * Earnings per share increased 41.4% yr/yr, driven by higher loan yields Result Drivers * INTEREST INCOME - Increase in interest income due to higher yields and volume in loan portfolio *...
Roku posts rise in quarterly revenue
Roku posts rise in quarterly revenue
Oct 30, 2025
(Reuters) -Roku ( ROKU ) reported a 14% rise in third-quarter revenue on Thursday, fueled by its expanding user base and advertising sales. The company reported revenue of $1.21 billion in the third quarter, compared to $1.06 billion a year ago. ...
Hanover Bancorp Q3 profit rises on higher net interest income 
Hanover Bancorp Q3 profit rises on higher net interest income 
Oct 30, 2025
Overview * Hanover Q3 net income rises to $3.5 mln, up from $2.4 mln in prior quarter * Net interest income grows 16.19% yr/yr to $15.2 mln * Company's net interest margin improves to 2.74% from 2.37% yr/yr Outlook * Company expects normalized effective tax rate of 25.0% for remainder of the year * Company sees continued influence from FOMC...
Gilead Sciences Q3 adjusted EPS beats estimates helped by higher demand for HIV products
Gilead Sciences Q3 adjusted EPS beats estimates helped by higher demand for HIV products
Oct 30, 2025
Overview * Gilead Q3 2025 total revenue rises 3% yr/yr to $7.8 bln * Adjusted EPS for Q3 2025 beats analyst expectations, per LSEG data * Product sales excluding Veklury increase 4% to $7.1 bln Outlook * Gilead raises full-year product sales guidance to $28.4 bln-$28.7 bln * Company increases full-year diluted EPS guidance to $6.65-$6.85 * Gilead anticipates multiple...
Copyright 2023-2026 - www.financetom.com All Rights Reserved